期刊文献+

CTLA-4启动子及外显子区域基因多态性与胃癌的相关性研究 被引量:1

Polymorphism of CTLA-4 gene promoter region and extron region in gastric cancer
下载PDF
导出
摘要 目的探讨细胞毒性T淋巴细胞相关抗原4(CTLA-4)基因外显子49位点及启动子1722位点单核苷酸多态性(SNP)与青岛地区人群胃癌发病率的相关性。方法采用聚合酶链反应-限制性片段长度多态法(PCR-RFLP)检测青岛地区胃癌患者、萎缩性胃炎及健康对照组患者中CTLA-4+49A/G及-1722T/C基因多态性的分布,并分析其多态性与胃癌临床病理特征的关系。结果萎缩性胃炎组及胃癌组CTLA-4外显子49位点AG及GG基因型的分布频率显著高于健康对照组(P<0.05),携带AG及GG基因型者较携带AA基因型者罹患胃癌的风险分别增加至2.63倍(95%CI:1.053~6.542)及5.69倍(95%CI:2.262~14.302),且男性胃癌患者携带AG及GG基因型明显增加。与健康对照组相比,胃癌组及萎缩性胃炎组的CTLA-4启动子1722位点各基因型分布差异无统计学意义(P>0.05),其多态性与胃癌患者的性别、年龄、肿瘤分化程度及TNM分期无相关性。结论 CTAL-4+49A/G基因多态性与胃癌的遗传易感性相关。 Objective To analyze the relationship between polymorphism in CTLA-4 gene extron 49 site and promoter 1722 and susceptibility to gastric cancer in Qingdao area. Methods Polymerase chain reaction-restriction fragment length polymorphism and direct sequencing were performed to analyze the genotype of the polymorphism in 49 site and 1722 site. Their correlation with clinico- pathological characteristics of gastric cancer was analyzed. Results The frequency of AG and GG genotype in 49 site in gastric cancer group and atrophic gastritis group were higher than those in the control group (P 〈 0. 05 ) ; and men with gastric cancer carried more AG and GG genotype than women. The frequency of all genotype in 1722 site in gastric cancer and atrophic gastritis group was not signifi- cantly different from control group. The single nucleotide polymorphism of promoter 1722 was not associated with gender, age, differenti- ation and TNM staging of gastric cancer. Conclusion There is a relationship between CTLA-4 + 49 A/G polymorphism and suscepti- bility to gastric cancer.
出处 《临床肿瘤学杂志》 CAS 2012年第9期828-831,共4页 Chinese Clinical Oncology
关键词 细胞毒性T淋巴细胞相关抗原4 多态性 单核苷酸 胃肿瘤 Cytotoxic T lymphocyte-associated antigen 4 Polymorphism Single nucleotide Stomach neoplasms
  • 相关文献

参考文献12

  • 1Kimura H, Kato Y, Shimizu S, et al. Association of polymorphism at position 49 in c'xon 1 of the cytotoxic T-lymphocyte-associated factor 4 gene with Graves' disease refractory to medical treatment, but not with amiodarone-associated thyroid dysfunction [J]. Thyroid, 2009, 19(9) :975 -781.
  • 2Pincerati MR, Dalla-Costa R, Pavoni DP, et al. Genetic polymorphisms of the T-cell coreceptors CD28 and CTLA-4 in Afro- and Euro-Brazilians[ J]. J Immunol,2010, 37 (4) :253 - 261.
  • 3Kennedy R, Celis E. Multiple roles for CD4 + T cells in anti- tumor immune responses [ J 1 hnmunol Rev, 2008, 222 ( 1 ) : 129 - 144.
  • 4Khalilzadeh O, Mojazi Amiri H, Tahvildari M et al. Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves' ophthalmopathy[ J]. Arch Dermatol Res, 2009, 301 (10) :719 -723.
  • 5Chen Z, Brant SR, Li C, et al. CTLA4-1661A/G and 3'UTR long repeat polymorphisms are associated with ulcerative colitis and influence CTLA4 mRNA and protein expression[ J ].Genes hnmun, 2010, 11 (7) :573 -583.
  • 6Osei-Hyiaman D, Hou L, Zhiyin R, et al. Association of a novel point mutation(C159G) of the CTLA4 gene with type 1 diabetes in West Africans but not in Chinese [ J ]. Diabetes, 2001,50 (9) :2169 -2171.
  • 7Han Q, Duan S, Zhang G, et al. Associations between cytotoxic T lymphocyte-associaled antigen-4 polymorphisms and serum tumor necrosis factor-α and interferon-y levels in patients with chronic hepatitis B virus infection [ J] .Inflamm Res, 2011, 60 (11) :1071 - 1078.
  • 8Hodi FA, Butler M, Oble DA, ct al. hnmunologie and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients[ J ]. Proc Natl Acad Sci USA, 2008,105 ( 8 ) : 3005 - 3010.
  • 9厚瑞萍,刘英超,陈自平,张传臻,徐昌青.胃癌易感性与细胞毒性T淋巴细胞相关抗原-4基因+49A/G多态性的关系[J].中华实验外科杂志,2009,26(6):747-749. 被引量:4
  • 10Qi P,Ruan CP,Wang H. CTLA--4 +49A > G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese [ J ]. Int J Colorectal Dis, 2010,25 ( 1 ) : 39 45.

二级参考文献10

  • 1杨维良,张新晨.胃癌基因治疗的现状及展望[J].中华实验外科杂志,2004,21(5):639-640. 被引量:11
  • 2宋继权,夏冰,李睿,李春,吴云华.胃癌与细胞毒性T淋巴细胞相关抗原-4基因启动子区域多态性的相关性研究[J].中华实验外科杂志,2006,23(11):1373-1374. 被引量:8
  • 3Chen L, Ashe S, Brady WA, et al. Costimulation of antitumor immunity by the B7 counterreceptor for the Tlymphocyte molecules CD28 and CTLA4. Cell, 1992,71 : 1093-1102.
  • 4Hodi FS, Butler M, Oble DA, et al. Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc Natl Acad Sci USA ,2008, 105:3005-3010.
  • 5Kouki T, Sawai Y, Gardine CA, et al. CTLA-4 gene polyrnorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol,2000, 165:6606-6611.
  • 6Hadinia A, Hossieni SV, Erfani N, et al. CTLA4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers. J Gastroenterol Hepatol, 2007,22 : 2283-2287.
  • 7Hudson LL, Rocca K, Song YW, et al. CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant asso2ciation with a determinant in the promoter region. Hum Genet,2002,111:452-455.
  • 8Ogawa S, Nitta K,Hara Y, et al. CD28 knockout mice as a uselul clue to examine the pathogenesis of chronic graft-versus-host reaction. Kidney Int,2000,58:2215-2220.
  • 9Shaw G, Kamen R. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell,1986,46:659-667.
  • 10Ligers A, Teleshova N, Masterman T, et al. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun,2001,2:145-152.

共引文献9

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部